Clinical interpretation of genomic variants from large next-generation panel (NGS), whole exome sequencing and whole transcriptome sequencing
Ended Purchase Order Awarded Last action
- Contract number
- 75N91022P00706
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $351,525
Award facts
- Opportunity
-
- 75N91022Q00100 Solicitation number
- Contract value 49% obligated
-
- $351,525.00 Current, with exercised options
- $723,300.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $220,775 | |
| Original award | $130,750 |
About this award
Qiagen, LLC was awarded a firm fixed price purchase order valued at approximately $723,300 by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. Under this contract, Qiagen will provide clinical interpretation of genomic variants from large next-generation panel testing, whole exome sequencing, and whole transcriptome sequencing. Performance will take place in Germantown, Maryland over a two year period concluding in July 2024. No set aside designation or subcontracting details were indicated. This contract supports the National Cancer Institute's mission to reduce the burden of cancer through genomic research and clinical applications.
Quick answers
Who was awarded contract 75N91022P00706?
75N91022P00706 was awarded to Qiagen, LLC by National Cancer Institute (National Institutes of Health) on July 29, 2022.
How much is contract 75N91022P00706 worth?
The government has obligated $351,525 on 75N91022P00706. Its potential value, with all options, is $723,300.
Was contract 75N91022P00706 competed?
The extent of competition for 75N91022P00706 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award